Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#566 OD: ON DEMAND - Subscription Models to Incentive Antimicrobial Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate

Population-based reimbursement for antibiotics will potentially support appropriate use while rewarding their societal benefit, but valuation will be key to success. This session will examine factors contributing to value in a subscription model.

Learning Objectives

Discuss positive externalities that impact a medical product’s value; Describe challenges to reimbursement based on population health benefits; Assess clinical outcome measures that could contribute to value determinations over time.


Monika Schneider, PhD


Christine Årdal, PhD, MBA

Kevin Ronneberg, MD

To be determined
Patrick Holmes, MS

avatar for Monika Schneider

Monika Schneider

Managing Associate, Duke-Margolis Center For Health Policy
Monika Schneider is a Managing Associate within the biomedical innovation team at the Duke-Margolis Center for Health Policy. Her work focuses incentive mechanisms and payment reform models that could encourage development in areas of medical unmet need. Monika's portfolio includes... Read More →

Kevin Ronneberg

Vice President and Medical Director, Health Initiatives, Health Partners
Dr. Ronneberg is Vice President, Health Initiatives and Medical Director for HealthPartners, a health solutions organization providing care, coverage and research. He has served as a committee member and advisor for regional and national organizations including the National Academies... Read More →

Patrick Holmes

Innovation Policy Team Lead, Pfizer Inc
Patrick Holmes, Senior Director, Innovation Policy Lead, heads a team with responsibility for developing global health policy initiatives and evidence across a series of policy issues in support of Pfizer’s R&D-driven business model. These global initiatives are designed to drive... Read More →

Christine Årdal

Senior Advisor, Norwegian Institute of Public Health
Årdal has worked for 20 years on access to medicines through different sectors. She was a co-lead for the DRIVE-AB research project which aimed to transform the way policymakers stimulate innovation, the sustainable use, and the equitable availability of novel antibiotics to meet... Read More →

Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD Virtual Event Horsham, PA 19044
  12: Value-Access, Forum